We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




DHEA Receptor Identified in Vascular Endothelial Cells

By Biotechdaily staff writers
Posted on 25 Jun 2002
A receptor for the adrenal hormone dehydroepiandrosterone (DHEA) has been located in the cells that make up the inner lining of blood vessels. More...
DHEA and the closely related DHEAS are made mainly in the adrenal gland and circulate in the bloodstream in higher concentrations than any other steroid hormone, including estrogen or testosterone. DHEA production declines after the age of puberty, dropping to around 20% of peak levels by age 75.

A report appearing in the June 14, 2002, issue of the Journal of Biological Chemistry describes how investigators from the University of Iowa (Iowa City, USA; www.uiowa.edu) chose a novel approach to find the elusive DHEA receptor. Rather than working with immune or liver cells, as is most often done, they searched for the receptor in the cells comprising the vascular endothelium. Moreover, the receptor was found localized on the exterior surface of the cells rather than the interior surface, where hormone receptors are usually found.

"The significance of our study is that it provides a scientific basis for further study of the DHEA action in humans,” said the study's lead investigator Dr. Joseph Dillon. "Our findings show that there is a receptor for DHEA on the inner lining cells of blood vessels. The receptor responds to levels of DHEA that circulate normally within the bloodstream and links DHEA to the production of nitric oxide. Unlike research with all the other major hormones and steroids, no one had previously been able to identify a receptor for DHEA in cells.”

The next step will be to completely isolate the receptor. This will allow testing of DHEA analogues in order to eventually develop medications that could have beneficial effects in a wide range of diseases, including cancer, heart disease, obesity and diabetes.



Related Links:
University of Iowa

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.